Replay available

BeyondSpring, Inc. (BYSI) Q4 2020 Earnings Call

BeyondSpring, Inc. (NASDAQ: BYSI) Q4 2020 earnings conference call, held 2021-04-30. Replay captured from the company's public earnings webcast.

Fri, April 30, 2021 at 8:30 AMendedReplay
BeyondSpring, Inc. (BYSI) Q4 2020 Earnings Call

Hosted by

Featured presenters

Maury Raycroft

Analyst, Jefferies

Elizabeth Serapak

Chief Financial Officer

Dr. Lan Huang

Co-Founder, Chairwoman & Chief Executive Officer

Dr. Ramon Mohanla

Executive Vice President, Research & Development and Chief Medical Officer

Andrew Erickson

Investor Relations

Richard Daly

Chief Operating Officer

Andy Hisse

Analyst, William Blair

Jason Gerberry

Analyst, Bank of America

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Beyondspring, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:05.274 Good morning and welcome to BeyondSpring's fourth quarter and full year 2020 00:00:05.274 -- 00:00:10.318 financial results conference call. At this time, all participants are in listen-only 00:00:10.318 -- 00:00:15.623 mode. Following management's prepared remarks, we will hold a brief question and answer 00:00:15.623 -- 00:00:20.767 session. To join the question queue, you may press star then 1 on your telephone 00:00:20.767 -- 00:00:25.491 keypad. Should you need assistance during the conference call, you may signal an operator 00:00:25.491 -- 00:00:28.112 by pressing star and 0. 00:00:28.112 -- 00:00:33.794 As a reminder, this call is being recorded today, April 30th, 2021. 00:00:33.794 -- 00:00:38.536 I would now like to turn the conference over to Andrew Erickson, Investor Relations. 00:00:38.536 -- 00:00:40.597 Please go ahead. 00:00:40.597 -- 00:00:43.058 Thank you, everyone, for joining today's call. 00:00:43.058 -- 00:00:47.080 I'd like to advise listeners that comments made on today's call may reflect forward-looking 00:00:47.080 -- 00:00:51.402 statements that are related to such matters as BeyondSpring's clinical and preclinical 00:00:51.402 -- 00:00:54.744 research and development activities and results. 00:00:54.744 -- 00:00:59.406 regulatory and commercial plans, industry trends, market potential, collaborative initiatives, 00:00:59.406 -- 00:01:04.448 and financial projections, among others. While management believes that assumptions, 00:01:04.448 -- 00:01:08.971 expectations, and projections are reasonable in view of the currently available information, 00:01:08.971 -- 00:01:13.253 we are cautioned not to place undue reliance on these forward-looking statements. 00:01:13.253 -- 00:01:17.334 The company's actual re...